ANKHD1 represses p21 (WAF1CIP1) promoter and promotes multiple myeloma cell growth (English)
- New search for: Dhyani, A.
- New search for: Machado-Neto, J.A.
- New search for: Favaro, P.
- New search for: Saad, S.T.O.
- New search for: Dhyani, A.
- New search for: Machado-Neto, J.A.
- New search for: Favaro, P.
- New search for: Saad, S.T.O.
In:
EUROPEAN JOURNAL OF CANCER -A-
;
51
, 2
;
252-259
;
2015
-
ISSN:
- Article (Journal) / Print
-
Title:ANKHD1 represses p21 (WAF1CIP1) promoter and promotes multiple myeloma cell growth
-
Contributors:Dhyani, A. ( author ) / Machado-Neto, J.A. ( author ) / Favaro, P. ( author ) / Saad, S.T.O. ( author )
-
Published in:EUROPEAN JOURNAL OF CANCER -A- ; 51, 2 ; 252-259
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2015-01-01
-
Size:8 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.994
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.994 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 51, Issue 2
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 127
-
Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise - A Sarcoma Patients EuroNet and European Organisation for Research and Treatment of CancerSoft Tissue and Bone Sarcoma Group initiativeDesmoid Working Group / Kasper, B. / Baumgarten, C. / Bonvalot, S. / Haas, R. / Haller, F. / Hohenberger, P. / Moreau, G. / van der Graaf, W.T.A. et al. | 2015
- 137
-
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumoursSpicer, J. / Baird, R. / Suder, A. / Cresti, N. / Corbacho, J.G. / Hogarth, L. / Frenkel, E. / Matsumoto, S. / Kawabata, I. et al. | 2015
- 146
-
Phase I clinical study of the toll-like receptor 9 agonist MGN1703 in patients with metastatic solid tumoursWeihrauch, M.R. / Richly, H. / von Bergwelt-Baildon, M.S. / Becker, H.J. / Schmidt, M. / Hacker, U.T. / Shimabukuro-Vornhagen, A. / Holtick, U. / Nokay, B. et al. | 2015
- 157
-
Clinical impact of herpesvirus entry mediator expression in human hepatocellular carcinomaHokuto, D. / Sho, M. / Yamato, I. / Yasuda, S. / Obara, S. / Nomi, T. / Nakajima, Y. et al. | 2015
- 166
-
Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trialsFaron, M. / Pignon, J.P. / Malka, D. / Bourredjem, A. / Douillard, J.Y. / Adenis, A. / Elias, D. / Bouche, O. / Ducreux, M. et al. | 2015
- 177
-
Recurrence and cancer-specific survival according to the expression of IL-4R@a and IL-13R@a1 in patients with oral cavity cancerKwon, M. / Kim, J.W. / Roh, J.L. / Park, Y. / Cho, K.J. / Choi, S.H. / Nam, S.Y. / Kim, S.Y. / Lee, B.H. et al. | 2015
- 186
-
Sporadic extra abdominal wall desmoid-type fibromatosis: Surgical resection can be safely limited to a minority of patientsColombo, C. / Miceli, R. / Le Pechoux, C. / Palassini, E. / Honore, C. / Stacchiotti, S. / Mir, O. / Casali, P.G. / Domont, J. et al. | 2015
- 193
-
Does aggressive local treatment have an impact on survival in children with metastatic rhabdomyosarcoma?Ben Arush, M. / Minard-Colin, V. / Mosseri, V. / Defachelles, A.S. / Bergeron, C. / Algret, N. / Fasola, S. / Andre, N. / Thebaud, E. et al. | 2015
- 202
-
Comparison of Response Evaluation Criteria in Solid Tumours and Choi criteria for response evaluation in patients with advanced soft tissue sarcoma treated with trabectedin: A retrospective analysisFrench Sarcoma Group / Taieb, S. / Saada-Bouzid, E. / Tresch, E. / Ryckewaert, T. / Bompas, E. / Italiano, A. / Guillemet, C. / Peugniez, C. et al. | 2015
- 210
-
Tenosynovial giant cell tumourpigmented villonodular synovitis: Outcome of 294 patients before the era of kinase inhibitorsPalmerini, E. / Staals, E.L. / Maki, R.G. / Pengo, S. / Cioffi, A. / Gambarotti, M. / Picci, P. / Daolio, P.A. / Parafioriti, A. et al. | 2015
- 218
-
Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancerVassal, G. / Rousseau, R. / Blanc, P. / Moreno, L. / Bode, G. / Schwoch, S. / Schrappe, M. / Skolnik, J. / Bergman, L. et al. | 2015
- 225
-
Risk factors for local recurrence in Wilms tumour and the potential influence of biopsy - The United Kingdom experienceRenal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG) / Irtan, S. / Jitlal, M. / Bate, J. / Powis, M. / Vujanic, G. / Kelsey, A. / Walker, J. / Mitchell, C. et al. | 2015
- 233
-
Mortality within 30days following systemic anti-cancer therapy, a review of all cases over a 4year period in a tertiary cancer centreKhoja, L. / McGurk, A. / O'Hara, C. / Chow, S. / Hasan, J. et al. | 2015
- 241
-
Towards better implementation of cancer screening in Europe through improved monitoring and evaluation and greater engagement of cancer registriesAnttila, A. / Lonnberg, S. / Ponti, A. / Suonio, E. / Villain, P. / Coebergh, J.W. / von Karsa, L. et al. | 2015
- 252
-
ANKHD1 represses p21 (WAF1CIP1) promoter and promotes multiple myeloma cell growthDhyani, A. / Machado-Neto, J.A. / Favaro, P. / Saad, S.T.O. et al. | 2015
- 260
-
Aberrant allele-switch imprinting of a novel IGF1R intragenic antisense non-coding RNA in breast cancersKang, L. / Sun, J. / Wen, X. / Cui, J. / Wang, G. / Hoffman, A.R. / Hu, J.F. / Li, W. et al. | 2015